BI Pharmaceuticals
Content & Collaboration Software · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(610) 793-4650Website
www.bi-touchpoint.comRevenue
$8 MillionIndustry
About BI Pharmaceuticals
Is BI Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at BI Pharmaceuticals
Funding: Get notified immidiatlly once BI Pharmaceuticals has new funding data
Click to see if BI Pharmaceuticals had a recent Job posting/layoffs
BI Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if BI Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when BI Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on BI Pharmaceuticals recently announced quarterly report
Check if BI Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined BI Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to BI Pharmaceuticals
Compare insights from companies similar to BI Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BI Pharmaceuticals
Company Profile Activity
Activity Insights
BI Pharmaceuticals is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
BI Pharmaceuticals is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about BI Pharmaceuticals.
BI Pharmaceuticals Tech Stack
A closer look at the technologies used by BI Pharmaceuticals
BI Pharmaceuticals News & Media
FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 9, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Jardiance® (empagliflozin) as an investigational treatment for adults with heart failure with preserved ejection fraction (HFpEF),...Nine Organizations Team Up to Present First ILD Day on September 15 to Drive Awareness of Interstitial Lung Disease
CHICAGO , Aug. 31, 2021 /PRNewswire/ -- To drive awareness of interstitial lung disease (ILD), nine organizations are collaborating to present the first-ever ILD Day on Wednesday, Sept. 15. There are more than 200 types of ILD, which is the umbrella term used for a large group of diseases...Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 27, 2021 /PRNewswire/ -- Full results from the landmark EMPEROR-Preserved phase III trial demonstrated that Jardiance® (empagliflozin) showed an impressive 21% relative risk reduction for the composite primary endpoint of cardiovascular death or...
Top Content & Collaboration Software Companies
Frequently Asked Questions Regarding BI Pharmaceuticals
Touchpoint Community Portal is a platform designed for community engagement and interaction. They offer services that aim to connect individuals and foster relationships within a community. Their target clients include organizations looking to enhance member communication and collaboration.... Read More